Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-26-091975
Filing Date
2026-08-06
Accepted
2026-08-06 16:04:22
Documents
84
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crvs-20260630x10q.htm   iXBRL 10-Q 2159161
2 EX-31.1 crvs-20260630xex31d1.htm EX-31.1 11829
3 EX-31.2 crvs-20260630xex31d2.htm EX-31.2 11767
4 EX-32.1 crvs-20260630xex32d1.htm EX-32.1 11822
5 GRAPHIC crvs-20260630x10q009.jpg GRAPHIC 52231
6 GRAPHIC crvs-20260630x10q010.jpg GRAPHIC 65247
7 GRAPHIC crvs-20260630x10q011.jpg GRAPHIC 51012
8 GRAPHIC crvs-20260630x10q012.jpg GRAPHIC 49895
9 GRAPHIC crvs-20260630x10q013.jpg GRAPHIC 48513
10 GRAPHIC crvs-20260630x10q014.jpg GRAPHIC 67674
  Complete submission text file 0001104659-26-091975.txt   9712993

Data Files

Seq Description Document Type Size
11 EX-101.SCH crvs-20260630.xsd EX-101.SCH 47837
12 EX-101.CAL crvs-20260630_cal.xml EX-101.CAL 54948
13 EX-101.DEF crvs-20260630_def.xml EX-101.DEF 247764
14 EX-101.LAB crvs-20260630_lab.xml EX-101.LAB 422029
15 EX-101.PRE crvs-20260630_pre.xml EX-101.PRE 363736
88 EXTRACTED XBRL INSTANCE DOCUMENT crvs-20260630x10q_htm.xml XML 1602243
Mailing Address 901 GATEWAY BLVD, THIRD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD, THIRD FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37719 | Film No.: 261248805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)